Corteva, Inc. (NYSE:CTVA) Holdings Boosted by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. boosted its position in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 30.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,818 shares of the company’s stock after purchasing an additional 1,341 shares during the period. J.W. Cole Advisors Inc.’s holdings in Corteva were worth $314,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors boosted its stake in shares of Corteva by 2.6% during the 1st quarter. Capital International Investors now owns 26,437,457 shares of the company’s stock valued at $1,524,648,000 after buying an additional 678,722 shares during the period. Northern Trust Corp boosted its stake in shares of Corteva by 2.5% during the 4th quarter. Northern Trust Corp now owns 12,815,795 shares of the company’s stock valued at $614,133,000 after buying an additional 310,012 shares during the period. Van ECK Associates Corp boosted its stake in shares of Corteva by 7.2% during the 1st quarter. Van ECK Associates Corp now owns 9,145,282 shares of the company’s stock valued at $527,409,000 after buying an additional 617,030 shares during the period. Harris Associates L P boosted its stake in shares of Corteva by 87.1% during the 4th quarter. Harris Associates L P now owns 9,011,702 shares of the company’s stock valued at $431,841,000 after buying an additional 4,194,981 shares during the period. Finally, Putnam Investments LLC boosted its stake in shares of Corteva by 12.9% during the 4th quarter. Putnam Investments LLC now owns 8,950,382 shares of the company’s stock valued at $428,902,000 after buying an additional 1,021,733 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Performance

NYSE:CTVA opened at $57.44 on Thursday. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $58.76. The company has a quick ratio of 1.17, a current ratio of 1.72 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $40.03 billion, a PE ratio of 72.71, a price-to-earnings-growth ratio of 1.60 and a beta of 0.77. The firm has a 50-day moving average price of $54.47 and a 200 day moving average price of $54.71.

Corteva (NYSE:CTVAGet Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.09. The company had revenue of $6.11 billion during the quarter, compared to analyst estimates of $6.15 billion. Corteva had a net margin of 5.31% and a return on equity of 7.30%. The company’s revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the business posted $1.60 earnings per share. Research analysts anticipate that Corteva, Inc. will post 2.69 earnings per share for the current fiscal year.

Corteva Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Tuesday, September 3rd were issued a dividend of $0.17 per share. This is a positive change from Corteva’s previous quarterly dividend of $0.16. The ex-dividend date was Tuesday, September 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.18%. Corteva’s dividend payout ratio (DPR) is presently 86.08%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CTVA. OTR Global reissued a “negative” rating on shares of Corteva in a research note on Friday, June 7th. Mizuho reduced their price objective on shares of Corteva from $61.00 to $60.00 and set a “buy” rating for the company in a research note on Tuesday, June 18th. Argus lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. reduced their price objective on shares of Corteva from $57.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $65.00 price objective on shares of Corteva in a research note on Wednesday, June 12th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $61.67.

Get Our Latest Stock Analysis on Corteva

About Corteva

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.